An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring ...

Association of ATM mutations in metastatic prostate cancer with differential genomic alteration profiles from homologous recombination deficient and proficient tumors. Change in management post- PSMA ...

68GaPSMA-11 PET/CT to monitor treatment response in patients with metastatic prostate cancer: The concordance between biochemical response and PSMA response.

A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an ...

The first Digital PET-CT Scanner at Mater Dei Hospital has been inaugurated and will be assisting cancer patients in their diagnosis and ongoing assessment. Present for the occasion were the Minister ...

PET-CT is a modern functional imaging modality which is obtained by a combination of PET (Positron emission tomography) and CT (computerised tomography) in a single examination. This combination ...

The purpose of this e-learning module is to develop a consensus based on evidence from existing systematic reviews, to make health care providers aware of the value and the appropriateness of the use ...

The proceeds of the financing were used by Avita to obtain a linear accelerator and PET/CT scanner for the new Jody M. Baker Cancer Center.

A retrospective real-world analysis presented at the 2025 ASH Annual Meeting and Exposition showed that circulating tumor DNA (ctDNA) detected at the end of treatment (EOT) was a prognostic indicator ...

The United States PET Scanners Market is projected to reach USD 1.07 billion by 2033, up from USD 0.82 billion in 2024, at a ...